Bridge Medicines appoints William J. Polvino as Chief Executive Officer

Monday, March 27, 2017 - 09:02 in Health & Medicine

As Chief Executive Officer of the newly formed drug discovery company, founded by Rockefeller University and its two neighboring institutions, Polvino will be responsible for building a portfolio of early-stage drug discovery projects and advancing each program from animal proof of principle to clinical trials. More »

Read the whole article on The Rockefeller University

More from The Rockefeller University

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net